Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 3Phase 1/2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Melanoma 25Hodgkin Disease 20Lymphoma 9Skin Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Leiomyosarcoma 3Neuroblastoma 2Neoplasms 2Uveal Melanoma 1Skin Diseases 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Melanoma, Cutaneous Malignant 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Liposarcoma 1

Interventions

Doxorubicin 25Ifosfamide 22Radiotherapy 17Etoposide 11Vincristine 10Cyclophosphamide 10Filgrastim 8Dactinomycin 8Trabectedin 7Chemotherapy, Adjuvant 5pazopanib 4Cisplatin 4Topotecan 3Radiation 3Neoadjuvant Therapy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Dacarbazine 3sargramostim 2etoposide phosphate 2eribulin 2Observation 2Methotrexate 2Mesna 2Imatinib Mesylate 2Gemcitabine 2Epirubicin 2Docetaxel 2Dexrazoxane 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma × Dacarbazine × Clear all
NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting
325 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

NCT03805022 2025-10-02

CIRSARC

Institut Bergonié

Phase 3 Recruiting
351 enrolled
Sarcoma

Sarcoma

NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Completed
16 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡